Showing results (1691-1700 of 1,805) with videos related to

Sort By:
Pageof 181
International Journal of Obesity (2005)|August 18, 2022
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweightMaria S Svane, Helle H Johannesen, Adam E Hansen, et al.
Orthodontics & Craniofacial Research|November 17, 2015
Structural outcomes in the Cleft Care UK study. Part 2: dento-facial outcomesR Al-Ghatam, T E M Jones, A J Ireland, et al.
Structure (London, England : 1993)|April 20, 2010
Structure of a virulence regulatory factor CvfB reveals a novel winged helix RNA binding moduleYasuhiko Matsumoto, Qingping Xu, Shinya Miyazaki, et al.
Environmental Monitoring and Assessment|June 29, 2020
Prioritizing river basins for intensive monitoring and assessment by the US Geological SurveyPeter C Van Metre, Sharon Qi, Jeffrey Deacon, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastasesIleana S Mauldin, Nolan A Wages, Anne M Stowman, et al.
Diabetes, Obesity & Metabolism|June 5, 2020
No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetesMaria S Svane, Helle H Johannesen, Christoffer Martinussen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed scheduleCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Ebiomedicine|June 21, 2016
Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human PlasmaNicolai J Wewer Albrechtsen, Daniel Hornburg, Reidar Albrechtsen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese menN Matikainen, S Söderlund, E Björnson, et al.
Pageof 181